Sheeno Thyparambil

1.7k total citations
41 papers, 614 citations indexed

About

Sheeno Thyparambil is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sheeno Thyparambil has authored 41 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Molecular Biology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sheeno Thyparambil's work include Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (8 papers) and Advanced Biosensing Techniques and Applications (6 papers). Sheeno Thyparambil is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (8 papers) and Advanced Biosensing Techniques and Applications (6 papers). Sheeno Thyparambil collaborates with scholars based in United States, Spain and China. Sheeno Thyparambil's co-authors include Todd Hembrough, Jon Burrows, Richard C. Jones, Ricky D. Edmondson, Peipei Ping, Chenggong Zong, Aldrin V. Gomes, David B. Krizman, Franco Cecchi and Marlene Darfler and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Circulation Research.

In The Last Decade

Sheeno Thyparambil

40 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheeno Thyparambil United States 12 401 231 126 109 90 41 614
Katharina Malinowsky Germany 17 389 1.0× 149 0.6× 76 0.6× 124 1.1× 177 2.0× 27 660
Victor Yip United States 11 367 0.9× 153 0.7× 217 1.7× 159 1.5× 52 0.6× 14 647
Hye-Jin Sung South Korea 10 350 0.9× 116 0.5× 112 0.9× 32 0.3× 94 1.0× 12 534
Miaolong Lu China 12 364 0.9× 87 0.4× 59 0.5× 36 0.3× 225 2.5× 18 607
Claire Faltermeier United States 9 225 0.6× 86 0.4× 70 0.6× 22 0.2× 93 1.0× 17 411
Shalini Anthwal Canada 8 312 0.8× 117 0.5× 65 0.5× 16 0.1× 140 1.6× 10 599
Baocai Xing China 6 289 0.7× 101 0.4× 80 0.6× 13 0.1× 117 1.3× 11 520
Frauke Henjes Germany 12 438 1.1× 74 0.3× 49 0.4× 101 0.9× 158 1.8× 18 579
Kelly Cooke United States 8 365 0.9× 186 0.8× 265 2.1× 25 0.2× 65 0.7× 13 584
Karol Jelonek Poland 16 542 1.4× 103 0.4× 69 0.5× 129 1.2× 289 3.2× 32 743

Countries citing papers authored by Sheeno Thyparambil

Since Specialization
Citations

This map shows the geographic impact of Sheeno Thyparambil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheeno Thyparambil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheeno Thyparambil more than expected).

Fields of papers citing papers by Sheeno Thyparambil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheeno Thyparambil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheeno Thyparambil. The network helps show where Sheeno Thyparambil may publish in the future.

Co-authorship network of co-authors of Sheeno Thyparambil

This figure shows the co-authorship network connecting the top 25 collaborators of Sheeno Thyparambil. A scholar is included among the top collaborators of Sheeno Thyparambil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheeno Thyparambil. Sheeno Thyparambil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michelini, Flavia, Joshua Z. Drago, Dazhi Liu, et al.. (2024). EGFR-directed antibodies promote HER2 ADC internalization and efficacy. Cell Reports Medicine. 5(11). 101792–101792. 12 indexed citations
2.
Thyparambil, Sheeno, et al.. (2024). Unveiling proteomic diversity: A quantitative study of antibody drug conjugate and chemotherapy targets in gastroesophageal cancer.. Journal of Clinical Oncology. 42(3_suppl). 261–261. 1 indexed citations
3.
Thyparambil, Sheeno, et al.. (2023). Personalized therapy for head and neck squamous carcinoma (HNSCC) utilizing tissue proteomics profiling.. Journal of Clinical Oncology. 41(16_suppl). 6045–6045. 1 indexed citations
4.
Thyparambil, Sheeno, et al.. (2023). Abstract 2160: Quantitative proteomics of antibody-drug conjugates and chemotherapy targets in prostate cancer. Cancer Research. 83(7_Supplement). 2160–2160. 1 indexed citations
5.
Li, Xiao, Bo Jin, Yun Ding, et al.. (2022). Serological Phenotyping Analysis Uncovers a Unique Metabolomic Pattern Associated With Early Onset of Type 2 Diabetes Mellitus. Frontiers in Molecular Biosciences. 9. 841209–841209. 5 indexed citations
6.
Cecchi, Francesca, Sainetra Sridhar, Melissa de los Reyes, et al.. (2020). 13P HER2 low testing in breast cancer: How to optimize detection. Annals of Oncology. 31. S21–S21. 3 indexed citations
7.
Hao, Shiying, Xiaoming Yao, Xiao Li, et al.. (2020). High-throughput quantitation of serological ceramides/dihydroceramides by LC/MS/MS: Pregnancy baseline biomarkers and potential metabolic messengers. Journal of Pharmaceutical and Biomedical Analysis. 192. 113639–113639. 14 indexed citations
8.
Serna, Garazi, Franco Cecchi, Roberta Fasani, et al.. (2019). Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer. Scientific Reports. 9(1). 13568–13568. 11 indexed citations
9.
Schaff, Lauren, Dongyao Yan, Sheeno Thyparambil, et al.. (2019). Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival. Journal of Neuro-Oncology. 146(1). 163–170. 26 indexed citations
10.
Thyparambil, Sheeno, Yeoun Jin Kim, Andrew G. Chambers, et al.. (2018). Abstract 778: Potential drug targets for adenoid cystic carcinoma elucidated by proteogenomic analysis. Cancer Research. 78(13_Supplement). 778–778. 2 indexed citations
11.
An, Eunkyung, Chan‐Young Ock, T.-Y. Kim, et al.. (2016). Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment. Annals of Oncology. 28(1). 110–115. 32 indexed citations
12.
Blackler, Adele, Wei‐Li Liao, Emily O’Day, et al.. (2016). Therapeutically Induced Changes in HER2, HER3, and EGFR Protein Expression for Treatment Guidance. Journal of the National Comprehensive Cancer Network. 14(5). 503–507. 7 indexed citations
13.
Nucíforo, Paolo, Sheeno Thyparambil, Claudia Aura, et al.. (2015). High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti‐HER2 therapy. Molecular Oncology. 10(1). 138–147. 68 indexed citations
14.
Catenacci, Daniel V.T., Wei-Li Liao, Lei Zhao, et al.. (2015). Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH. Gastric Cancer. 19(4). 1066–1079. 31 indexed citations
15.
16.
Catenacci, Daniel V.T., Wei‐Li Liao, Sheeno Thyparambil, et al.. (2014). Absolute Quantitation of Met Using Mass Spectrometry for Clinical Application: Assay Precision, Stability, and Correlation with MET Gene Amplification in FFPE Tumor Tissue. PLoS ONE. 9(7). e100586–e100586. 40 indexed citations
17.
Nucíforo, Paolo, Sheeno Thyparambil, Ana C. Garrido-Castro, et al.. (2014). Correlation of high levels of HER2 measured by multiplex mass spectrometry with increased overall survival in patients treated with anti-HER2-based therapy.. Journal of Clinical Oncology. 32(15_suppl). 649–649. 1 indexed citations
18.
Hembrough, Todd, Sheeno Thyparambil, Wei-Li Liao, et al.. (2013). Application of Selected Reaction Monitoring for Multiplex Quantification of Clinically Validated Biomarkers in Formalin-Fixed, Paraffin-Embedded Tumor Tissue. Journal of Molecular Diagnostics. 15(4). 454–465. 48 indexed citations
19.
Hembrough, Todd, Sheeno Thyparambil, Wei‐Li Liao, et al.. (2012). Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue. Clinical Proteomics. 9(1). 5–5. 50 indexed citations
20.
Gomes, Aldrin V., Chenggong Zong, Ricky D. Edmondson, et al.. (2005). The Murine Cardiac 26S Proteasome: An Organelle Awaiting Exploration. Annals of the New York Academy of Sciences. 1047(1). 197–207. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katharina Malinowsky Breakdown of academic impact, for papers by Victor Yip Breakdown of academic impact, for papers by Hye-Jin Sung Breakdown of academic impact, for papers by Miaolong Lu Breakdown of academic impact, for papers by Claire Faltermeier Breakdown of academic impact, for papers by Shalini Anthwal Breakdown of academic impact, for papers by Baocai Xing Breakdown of academic impact, for papers by Frauke Henjes Breakdown of academic impact, for papers by Kelly Cooke Breakdown of academic impact, for papers by Karol Jelonek
Rankless by CCL
2026